Skip to main content
. Author manuscript; available in PMC: 2009 Aug 1.
Published in final edited form as: Cancer Res. 2008 Aug 1;68(15):6162–6170. doi: 10.1158/0008-5472.CAN-08-0144

Table 1.

Clinical characteristics of the study population

All Cases
(n = 60)
African-American
(n = 30)
European-American
(n = 30)
P value2
t-test

Age at prostatectomy median (range) n = 60 60 (47 – 73) 61 (48 – 72) 60 (47 – 73) 0.91

PSA at diagnosis median (range) n = 441 6.1 (1.3 – 47.7) 6.0 (1.3 – 47.7) 6.1 (4.0 – 20.0) 0.67

Largest individual nodule (grams) median (range) n = 511 1.6 (0.2 – 2.9) 1.5 (0.8 – 2.9) 1.6 (0.2 – 2.8) 0.78

N (%) N (%) N (%) Fisher’s exact test

Source of tissue
   NCI CPCTR 52 (87) 27 (90) 25 (83)
   University of Maryland 8 (13) 3 (10) 5 (17) 0.71

Gleason sum score
   < 7 (5–6) 15 (25) 8 (27) 7 (23)
   ≥ 7 (7–9) 45 (75) 22 (73) 23 (77) 1.0

Extraprostatic extension1
   No 35 (67) 19 (70) 16 (64)
   Yes 17 (33) 8 (30) 9 (36) 0.77

Surgical margin status1
   Negative 30 (59) 17 (63) 13 (54)
   Positive 21 (41) 10 (37) 11 (46) 0.58

Seminal vesicle invasion1
   No 43 (83) 20 (74) 23 (92)
   Yes 9 (17) 7 (26) 2 (8) 0.14
1

Cases with unknown status are not included.

2

P value for difference between African-Americans and European-Americans